Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Abecassis

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survivalAhsun Riaz, Robert K Ryu, Laura M Kulik, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2009
Transplant tourism and unregulated black-market trafficking of organsThomas Starzl, Lewis Teperman, David Sutherland, et al.
Cardiovascular and Interventional Radiology|February 8, 2020
Correction to: Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and ValidationRehan Ali, Yihe Yang, Mark Antkowiak, et al.
Cardiovascular and Interventional Radiology|March 3, 2019
Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and ValidationRehan Ali, Yihe Yang, Mark Antkowiak, et al.
JAMA|March 18, 2010
Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinomaAhsun Riaz, Frank H Miller, Laura M Kulik, et al.
Journal of Hepatology|July 2, 2013
Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resectionMichael Vouche, Robert J Lewandowski, Rohi Atassi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2008
Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conferenceMichael Abecassis, Stephen T Bartlett, Allan J Collins, et al.
Gastroenterology|August 31, 2016
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular CarcinomaRiad Salem, Andrew C Gordon, Samdeep Mouli, et al.
Cardiovascular and Interventional Radiology|April 7, 2021
Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient AnalysisMonica M Matsumoto, Samdeep Mouli, Priyali Saxena, et al.
Gastroenterology|September 22, 2009
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomesRiad Salem, Robert J Lewandowski, Mary F Mulcahy, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survivalAhsun Riaz, Robert K Ryu, Laura M Kulik, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2009
Transplant tourism and unregulated black-market trafficking of organsThomas Starzl, Lewis Teperman, David Sutherland, et al.
Cardiovascular and Interventional Radiology|February 8, 2020
Correction to: Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and ValidationRehan Ali, Yihe Yang, Mark Antkowiak, et al.
Cardiovascular and Interventional Radiology|March 3, 2019
Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and ValidationRehan Ali, Yihe Yang, Mark Antkowiak, et al.
JAMA|March 18, 2010
Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinomaAhsun Riaz, Frank H Miller, Laura M Kulik, et al.
Journal of Hepatology|July 2, 2013
Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resectionMichael Vouche, Robert J Lewandowski, Rohi Atassi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2008
Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conferenceMichael Abecassis, Stephen T Bartlett, Allan J Collins, et al.
Gastroenterology|August 31, 2016
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular CarcinomaRiad Salem, Andrew C Gordon, Samdeep Mouli, et al.
Cardiovascular and Interventional Radiology|April 7, 2021
Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient AnalysisMonica M Matsumoto, Samdeep Mouli, Priyali Saxena, et al.
Gastroenterology|September 22, 2009
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomesRiad Salem, Robert J Lewandowski, Mary F Mulcahy, et al.
Pageof 12